Cargando…
Elevated Soluble Podoplanin Associates with Hypercoagulability in Patients with Nephrotic Syndrome
Podoplanin (PDPN) promotes platelet aggregation and activation by interacting with C-type lectin-like receptor 2(CLEC-2) on platelets. The interaction between the upregulated PDPN and platelet CLEC-2 stimulates venous thrombosis. PDPN was identified as a risk factor for coagulation and thrombosis in...
Autores principales: | Ji, Ying, Wang, Yan-Li, Xu, Fang, Jia, Xi-Bei, Mu, Su-Hong, Lyu, Hui-Yan, Yuan, Xue-Ying, Na, Shi-Ping, Bao, Yu-Shi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310221/ https://www.ncbi.nlm.nih.gov/pubmed/35862263 http://dx.doi.org/10.1177/10760296221108967 |
Ejemplares similares
-
Plasma Soluble Podoplanin as a Biomarker of Hypercoagulability and Cellular Immunity Status in Patients With Non-small Cell Lung Cancer
por: Zhang, Qian, et al.
Publicado: (2023) -
The Detection of Hypercoagulability in
Patients with Acute Cerebral Infarction
Using a Clot Waveform Analysis
por: Kamon, Toshitaka, et al.
Publicado: (2023) -
The Association of Syndecan-1, Hypercoagulable State and Thrombosis and in Patients With Nephrotic Syndrome
por: Chen, Xin, et al.
Publicado: (2021) -
Hypercoagulation and elevation of blood triglycerides are characteristics of Kawasaki disease
por: Chen, Xi, et al.
Publicado: (2015) -
Clinical Efficacy of Soluble Thrombomodulin, Tissue Plasminogen
Activator Inhibitor complex, Thrombin-Antithrombin
complex,α2-Plasmininhibitor-Plasmin complex in Pediatric Sepsis
por: Li, Juanzhen, et al.
Publicado: (2022)